24-norursodeoxycholic acid has been researched along with cenicriviroc in 1 studies
| Studies (24-norursodeoxycholic acid) | Trials (24-norursodeoxycholic acid) | Recent Studies (post-2010) (24-norursodeoxycholic acid) | Studies (cenicriviroc) | Trials (cenicriviroc) | Recent Studies (post-2010) (cenicriviroc) |
|---|---|---|---|---|---|
| 35 | 2 | 27 | 52 | 12 | 46 |
| Protein | Taxonomy | 24-norursodeoxycholic acid (IC50) | cenicriviroc (IC50) |
|---|---|---|---|
| C-C chemokine receptor type 7 | Homo sapiens (human) | 0.0031 | |
| C-C chemokine receptor type 2 | Homo sapiens (human) | 0.0059 | |
| C-C chemokine receptor type 5 | Homo sapiens (human) | 0.003 | |
| C-C chemokine receptor type 5 | Mus musculus (house mouse) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ | 1 |
1 review(s) available for 24-norursodeoxycholic acid and cenicriviroc
| Article | Year |
|---|---|
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid | 2019 |